We are live on ! Find out more
UOC

UBS O'Connor Portfolio holdings

AUM $3.76B
1-Year Est. Return 62.41%
This Fund
S&P 500
This Quarter Est. Return
+7.76%
1 Year Est. Return
+62.41%
3 Year Est. Return
+179.84%
5 Year Est. Return
+371.69%
10 Year Est. Return
+1,534.25%
AUM
$4.75B
AUM Growth
+$529M
Cap. Flow
+$146M
Cap. Flow %
3.08%
Top 10 Hldgs %
47.97%
Holding
745
New
128
Increased
150
Reduced
259
Closed
162
Avg Time Held Equity + Options
3.8 quarters
Top 10 Avg Time Held Equity + Options
1.1 quarters
Top 20 Avg Time Held Equity + Options
1.1 quarters
Avg Time Held Equity only
3.9 quarters
Top 10 Avg Time Held Equity only
1.1 quarters
Top 20 Avg Time Held Equity only
1.1 quarters

Sector Composition

Rank Sector Weight
1 Healthcare 32.35%
2 Technology 15.68%
3 Financials 11.99%
4 Miscellaneous 10.5%
5 Real Estate 8.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
SPWR icon
326
SunPower Inc
SPWR
$56.9M
$1.43M 0.03%
135,081
-1,666
-1% -$17.4K
2021 Q2
8 quarters
ADT icon
327
ADT
ADT
$4.78B
$1.38M 0.03%
229,607
-16,575
-7% -$104K
2018 Q2
20 quarters
SWKS icon
328
Skyworks Solutions
SWKS
$11.4B
$1.38M 0.03%
12,506
-3,500
-22% -$369K
2023 Q1
1 quarter
HLVX icon
329
DELISTED
HilleVax
HLVX
$1.38M 0.03%
80,478
-789
-1% -$12.2K
2022 Q2
4 quarters
ZURA icon
330
Zura Bio
ZURA
$388M
$1.37M 0.03%
+167,167
New +$1.34M
2023 Q2
0 quarters
IFRX icon
331
InflaRx
IFRX
$237M
$1.36M 0.03%
+305,000
New +$1.37M
2023 Q2
0 quarters
ZM icon
332
Zoom
ZM
$28.5B
$1.36M 0.03%
20,000
+5,000
+33% +$334K
2023 Q1
1 quarter
VZIO icon
333
DELISTED
VIZIO Holding Corp.
VZIO
$1.35M 0.03%
+200,000
New +$1.55M
2023 Q2
0 quarters
ADPT icon
334
Adaptive Biotechnologies
ADPT
$4.03B
$1.34M 0.03%
199,840
+21,254
+12% +$158K
2022 Q1
5 quarters
PSQH icon
335
PSQ Holdings
PSQH
$13.8M
$1.33M 0.03%
8,619
-22,889
-73% -$3.49M
2021 Q3
7 quarters
RIGL icon
336
Rigel Pharmaceuticals
RIGL
$908M
$1.32M 0.03%
102,677
+26,926
+36% +$364K
2022 Q1
5 quarters
IRTC icon
337
iRhythm Holdings
IRTC
$3.51B
$1.31M 0.03%
12,529
-3,186
-20% -$383K
2023 Q1
1 quarter
WELL icon
338
Welltower
WELL
$164B
$1.3M 0.03%
16,087
-22,285
-58% -$1.72M
2022 Q3
3 quarters
ACRV icon
339
Acrivon Therapeutics
ACRV
$81.8M
$1.3M 0.03%
+100,000
New +$1.21M
2023 Q2
0 quarters
FUSN icon
340
DELISTED
Fusion Pharmaceuticals Inc. Common Shares
FUSN
$1.28M 0.03%
274,568
+32,542
+13% +$141K
2022 Q3
3 quarters
SVRA icon
341
Savara
SVRA
$1B
$1.28M 0.03%
400,352
-156,161
-28% -$367K
2022 Q2
4 quarters
AUTL icon
342
Autolus Therapeutics
AUTL
$468M
$1.26M 0.03%
530,919
-226,089
-30% -$536K
2022 Q1
5 quarters
JAQC
343
DELISTED
Jupiter Acquisition Corporation Common stock
JAQC
$1.23M 0.03%
120,173
-352,449
-75% -$3.58M
2021 Q4
6 quarters
CCJ icon
344
Cameco
CCJ
$37.6B
$1.23M 0.03%
+39,300
New +$1.11M
2023 Q2
0 quarters
OFIX icon
345
Orthofix Medical
OFIX
$376M
$1.23M 0.03%
68,032
+3,352
+5% +$62.6K
2023 Q1
1 quarter
TRIS icon
346
DELISTED
Tristar Acquisition I Corp.
TRIS
$1.22M 0.03%
116,910
-2,635
-2% -$27.5K
2021 Q4
6 quarters
RLAY icon
347
Relay Therapeutics
RLAY
$3.89B
$1.21M 0.03%
96,385
+52,285
+119% +$650K
2022 Q4
2 quarters
BCAB icon
348
DELISTED
BIOATLA INC
BCAB
$1.21M 0.03%
8,054
+3,153
+64% +$542K
2022 Q3
3 quarters
MSTR icon
349
Strategy Inc
MSTR
$60.9B
$1.2M 0.03%
+35,050
New +$1.06M
2023 Q2
0 quarters
GWRE icon
350
Guidewire Software
GWRE
$13.7B
$1.14M 0.02%
15,000
-87,500
-85% -$6.7M
2023 Q1
1 quarter

Similar funds

UBS O'Connor's Q2 2023 Portfolio in Review

As of Q2 2023, UBS O'Connor held 745 positions worth $4.75B, up 13% from $4.22B the previous quarter. Its ten largest holdings account for 48% of the portfolio.

UBS O'Connor deployed $146M of net new capital in Q2 2023, opening 128 new positions and adding to 150 existing holdings. Its largest new stake was PDC Energy, Inc.: 3,101,445 shares worth $221M.

By sector, the portfolio is most concentrated in Healthcare at 32% of assets, up from 21% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Tower Semiconductor, an estimated $50.8M trimmed.

  • UBS O'Connor's largest Q2 2023 buy was PDC Energy, Inc.: 3,101,445 shares worth $221M.
  • UBS O'Connor added most to Seagen Inc. Common Stock in Q2 2023, an estimated $253M increase.
  • UBS O'Connor's biggest Q2 2023 reduction was Tower Semiconductor, cutting an estimated $50.8M.
  • UBS O'Connor fully exited First Horizon in Q2 2023, selling an estimated $179M.
  • UBS O'Connor's ten largest holdings make up 48% of its $4.75B portfolio in Q2 2023.
  • UBS O'Connor opened 128 new positions and closed 162 in Q2 2023.
  • UBS O'Connor's portfolio value rose 13% quarter-over-quarter to $4.75B.

Based on UBS O'Connor's 13F filing for Q2 2023, filed 14 Aug 2023.